[北京]诺和诺德（中国）制药有限公司

职能类别:大学/大专应届毕业生

Key areas of responsibility

1)To understand new drug development process globally and locally in China.
2)To understand the relevant regulation requirement in medical writing area
3)To involve in reporting of clinical trial results to support new drug development.
4)To involve in writing scientific publications (e.g. congress abstracts, peer-reviewed manuscripts) to support medical communication of new drug as well as marketed drug.
5)To cooperate with team members for assigned project tasks.
6)To contribute to the development and improvement of IGP, and to support the program in attracting potential candidates.
7)To live the Novo Nordisk Way of Management and incorporate this in all actions.

And the job requirements are:

1)Education background of pharmaceutical sciences or medical science.
2)Logical thinking and strong analyzing skills.
3)Clear and concise language skills (EN, CN) for medical communication.
4)Reader-oriented writing mindset.
5)Drives expert dialogue and composes expert opinions in written in scientifically robust way.
6)Be able to communicate with highly professional individuals in a reliable, professional and trustworthy manner.
7)Planning, organizing and execution capability.
8)Communication and presentation skills.
9)Quality mindset.
10)Be passionate and proactive.
11)Learning Agility.
12)Self-motivated.
13)Fosters innovation and continuous improvement.
14)Drives Performance and result oriented.
15)Collaborates Across Boundaries.

公司名称:诺和诺德（中国）制药有限公司 公司类型:外资（非欧美） 公司介绍:Novo Nordisk Introduction In Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions. Diabetes poses one of today’s biggest global health challenges. We work for a future where fewer people get diabetes, everyone with diabetes is diagnosed, and everyone who is diagnosed receives adequate treatment and can live a life with as few limitations as possible.   Since the company was founded in Denmark more than 90 years ago, we have been changing diabetes. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Our ambition is to take the lead in each of these areas, driving change with an unfailing belief that it can be done. Our key contribution is to discover and develop better biological medicines, manufacture them to meet increasing global demand and make them accessible wherever they are needed. We are committed to finding the next generation of medicines and long-term investments in innovation have made us experts in the field of modern biotechnology. Producing life-saving medicines is a significant responsibility: millions of people depend on us. However, to defeat a serious chronic condition, we need to do more than supply the right medicine. This is why we work in partnerships with patients, policymakers, healthcare professionals and non-governmental organisations to raise awareness, improve prevention, promote earlier diagnosis and expand access to care. We have built our business on the conviction that the formula for lasting success is to stay focused, think long-term and do business in a financially, socially and environmentally responsible way.